✦ LIBER ✦
7501 ORAL Continuous daily dosing (CDD) study of sunitinib malate (SU) in patients (pts) with advanced GIST compares favorably with intermittent dosing
✍ Scribed by Blay, J.Y.; George, S.; Casali, P.G.; Le Cesne, A.; Morgan, J.A.; Pokela, J.; Quigley, M.T.; Tassell, V.; Baum, C.M.; Demetri, G.D.
- Book ID
- 123413029
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 59 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.